Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥6.4t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Summit Therapeutics

Market Cap: US$13.5b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

BioMarin Pharmaceutical

Market Cap: US$10.2b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Corcept Therapeutics

Market Cap: US$9.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Haisco Pharmaceutical Group

Market Cap: CN¥58.9b

Researches, develops, manufactures, and sells pharmaceutical products primarily in China.

Caliway Biopharmaceuticals

Market Cap: NT$248.1b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Praxis Precision Medicines

Market Cap: US$6.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

CSPC Innovation Pharmaceutical

Market Cap: CN¥42.0b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Vaxcyte

Market Cap: US$5.8b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Zealand Pharma

Market Cap: DKK 34.2b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Crinetics Pharmaceuticals

Market Cap: US$4.8b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Alkermes

Market Cap: US$4.7b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Immunovant

Market Cap: US$4.6b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

Kolon TissueGene

Market Cap: ₩6.7t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Hikma Pharmaceuticals

Market Cap: UK£3.3b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Dong-E-E-JiaoLtd

Market Cap: CN¥31.4b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

Shanghai Henlius Biotech

Market Cap: HK$33.2b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Viking Therapeutics

Market Cap: US$4.2b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Arcellx

Market Cap: US$4.2b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Legend Biotech

Market Cap: US$4.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Siegfried Holding

Market Cap: CHF 3.2b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥27.0b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

Genscript Biotech

Market Cap: HK$28.1b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Ultragenyx Pharmaceutical

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Mirum Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

CG Oncology

Market Cap: US$3.3b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Amicus Therapeutics

Market Cap: US$3.3b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Ocular Therapeutix

Market Cap: US$3.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Telix Pharmaceuticals

Market Cap: AU$4.5b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Soleno Therapeutics

Market Cap: US$2.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Wave Life Sciences

Market Cap: US$2.8b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Dyne Therapeutics

Market Cap: US$2.8b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Beam Therapeutics

Market Cap: US$2.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

PharmaResearch

Market Cap: ₩4.0t

Operates as a biopharmaceutical company primarily in South Korea.

Ascentage Pharma Group International

Market Cap: HK$21.0b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

SCHOTT Pharma KGaA

Market Cap: €2.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.